|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-1-1
|
|
pubmed:abstractText |
We have shown that DNA methylation of the PITX2 gene predicts risk of distant recurrence in steroid hormone receptor-positive, node-negative breast cancer. Here, we present results from a multicenter study investigating whether PITX2 and other candidate DNA methylation markers predict outcome in node-positive, estrogen receptor-positive, HER-2-negative breast cancer patients who received adjuvant anthracycline-based chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:CroweM CMC,
pubmed-author:DietrichDimoD,
pubmed-author:Eppenberger-CastoriSerenellaS,
pubmed-author:FassbenderAnneA,
pubmed-author:FoekensJohn AJA,
pubmed-author:HarbeckNadiaN,
pubmed-author:HartmannOliverO,
pubmed-author:LereboursFlorenceF,
pubmed-author:LescheRalfR,
pubmed-author:MaierSabineS,
pubmed-author:MartensJohn W MJW,
pubmed-author:NiemannStephanS,
pubmed-author:SchmittManfredM,
pubmed-author:SpyratosFrédériqueF,
pubmed-author:VuaroqueauxVincentV,
pubmed-author:WelzelKatrinK
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
315-23
|
|
pubmed:meshHeading |
pubmed-meshheading:19118060-Anthracyclines,
pubmed-meshheading:19118060-Biological Markers,
pubmed-meshheading:19118060-Breast Neoplasms,
pubmed-meshheading:19118060-Chemotherapy, Adjuvant,
pubmed-meshheading:19118060-DNA Methylation,
pubmed-meshheading:19118060-Female,
pubmed-meshheading:19118060-Genes, erbB-2,
pubmed-meshheading:19118060-Homeodomain Proteins,
pubmed-meshheading:19118060-Humans,
pubmed-meshheading:19118060-Lymphatic Metastasis,
pubmed-meshheading:19118060-Neoplasms, Hormone-Dependent,
pubmed-meshheading:19118060-Prognosis,
pubmed-meshheading:19118060-Receptors, Estrogen,
pubmed-meshheading:19118060-Transcription Factors,
pubmed-meshheading:19118060-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy.
|
|
pubmed:affiliation |
Epigenomics AG, Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
